Late Life Geriatric Depression

banner image

Late Life Geriatric Depression


Late-Life Depression, also known as Geriatric Depression, refers to depressive disorders occurring in individuals typically aged 65 and older. 


This condition is a significant public health concern, often underdiagnosed and undertreated, yet it profoundly impacts the quality of life, increases disability, and is associated with poorer outcomes for other medical conditions common in older adults. 


However, a highly relevant article that discusses Deep TMS for Late Life Geriatric Depression is  https://braintherapytms.com/late-life-geriatric-depression/

More about Deep TMS for Late Life Geriatric Depression?

Conventional approaches

Traditional treatments like antidepressants and psychotherapy can be effective, but older adults may face unique challenges such as polypharmacy (taking multiple medications), increased sensitivity to side effects, and cognitive issues that can complicate adherence to therapy.



Deep Transcranial Magnetic Stimulation (Deep TMS) offers a significant advancement in the treatment of late-life geriatric depression. 


This non-invasive therapy uses magnetic pulses to stimulate specific brain regions and networks known to be dysregulated in depression.


BrainsWay's H-coil design is particularly advantageous for elderly patients, as age-related changes like increased scalp-cortical distance can benefit from its deeper and broader electric field penetration.


Clinical studies have demonstrated the safety and significant efficacy of Deep TMS in older adults, providing a valuable option for this vulnerable population.



Patients aged 60 and above have shown remarkably high response rates, with up to nearly 80% experiencing a significant reduction in their depressive symptoms. 


More impressively, over 60% of these patients achieved full remission, meaning their depressive symptoms largely resolved to below clinical thresholds.  


 

These significant improvements often begin to emerge relatively quickly, with a median onset of response typically seen within just a few weeks of treatment. 


Crucially, Deep TMS maintains its high efficacy even in older brains, addressing age-related factors like increased scalp-cortex distance. 

Attention!

You are viewing a page that is not intended for persons in the United States, and includes information about treatment applications that HAVE NOT BEEN CLEARED by the FDA for safety and efficacy.


However, BrainsWay Deep TMS™ has received the European CE Mark for the treatment of many conditions.

 

This significant approval underscores the therapy's established safety and efficacy for these indications in Europe. While regulatory statuses vary by region, this CE Mark highlights the recognized potential of Deep TMS as a therapeutic option for:


Major Depressive Disorder (MDD)

Anxiety Depression

Obsessive-Compulsive Disorder (OCD)

Smoking Cessation

Alzheimer's Disease (AD)

Autism

Bipolar Disorder

Chronic Pain

Multiple Sclerosis (MS)

Parkinson's Disease

Post-Stroke Rehabilitation

Post-Traumatic Stress Disorder (PTSD)

Negative Symptoms of Schizophrenia

  



See What they said

"I feel different, my cognitive abilities are back, and now I'm enjoying life and even planning to go back to school." 

 — BrainsWay Deep TMS®  Patient 

"My experience with TMS has profoundly changed my life."

— BrainsWay Deep TMS®  Patient

"Feeling in the moment, enjoying life.Now I'm just leading a great life, thanks to  BrainsWay Deep TMS®  for OCD."

— BrainsWay Deep TMS®  Patient